| Steven Franks, MD | |
|
625 19th St S, Birmingham, AL 35233 | |
| (205) 934-3640 | |
| Not Available |
| Full Name | Steven Franks |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 625 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225423437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 35671 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prattville Baptist Hospital | Prattville, AL | Hospital |
| Baptist Medical Center South | Montgomery, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Services Of Montgomery Pc | 6608028204 | 55 |
News Archive
Taking a high dose of icosapent ethyl-a pure and stable prescription form of the omega-3 fatty acid known as EPA-significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Kaiser Health News staff writer Mary Agnes Carey reports: "By Sept. 23, the six month anniversary of the enactment of the health overhaul, many of the law's provisions will be in effect.
AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.
New research might bring a frown to even the most heavily botoxed faces, with scientists finding how some of the potent toxin used for cosmetic surgery escapes into the central nervous system.
› Verified 6 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Taking a high dose of icosapent ethyl-a pure and stable prescription form of the omega-3 fatty acid known as EPA-significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Kaiser Health News staff writer Mary Agnes Carey reports: "By Sept. 23, the six month anniversary of the enactment of the health overhaul, many of the law's provisions will be in effect.
AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.
New research might bring a frown to even the most heavily botoxed faces, with scientists finding how some of the potent toxin used for cosmetic surgery escapes into the central nervous system.
› Verified 6 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20050218000756 |
News Archive
Taking a high dose of icosapent ethyl-a pure and stable prescription form of the omega-3 fatty acid known as EPA-significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Kaiser Health News staff writer Mary Agnes Carey reports: "By Sept. 23, the six month anniversary of the enactment of the health overhaul, many of the law's provisions will be in effect.
AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.
New research might bring a frown to even the most heavily botoxed faces, with scientists finding how some of the potent toxin used for cosmetic surgery escapes into the central nervous system.
› Verified 6 days ago
| Entity Name | Emergency Services Of Montgomery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528310323 PECOS PAC ID: 6608028204 Enrollment ID: O20121205000519 |
News Archive
Taking a high dose of icosapent ethyl-a pure and stable prescription form of the omega-3 fatty acid known as EPA-significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Kaiser Health News staff writer Mary Agnes Carey reports: "By Sept. 23, the six month anniversary of the enactment of the health overhaul, many of the law's provisions will be in effect.
AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.
New research might bring a frown to even the most heavily botoxed faces, with scientists finding how some of the potent toxin used for cosmetic surgery escapes into the central nervous system.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Franks, MD 625 19th St S, Birmingham, AL 35233-1900 Ph: (205) 934-3640 | Steven Franks, MD 625 19th St S, Birmingham, AL 35233 Ph: (205) 934-3640 |
News Archive
Taking a high dose of icosapent ethyl-a pure and stable prescription form of the omega-3 fatty acid known as EPA-significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Kaiser Health News staff writer Mary Agnes Carey reports: "By Sept. 23, the six month anniversary of the enactment of the health overhaul, many of the law's provisions will be in effect.
AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.
New research might bring a frown to even the most heavily botoxed faces, with scientists finding how some of the potent toxin used for cosmetic surgery escapes into the central nervous system.
› Verified 6 days ago
Janyce M Sanford, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1806 Sixth Avenue South, Birmingham, AL 35249 Phone: 205-975-7389 Fax: 205-975-4662 | |
Dr. Elizabeth Holcombe Adams, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 218 Devon Dr, Birmingham, AL 35209 Phone: 662-368-8602 | |
Dr. Melissa Leigh Peters, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-9587 Fax: 205-975-4623 | |
Alan Frederick Kitchens, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 50 Medical Park Dr E, St. Vincent's East, Birmingham, AL 35235 Phone: 205-545-9530 Fax: 205-545-9529 | |
John Gullett, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5038 | |
Dr. Edward Payson Daugherty, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 151 Narrows Pkwy, Suite 110, Birmingham, AL 35242 Phone: 205-444-9550 Fax: 205-314-3360 | |
Mary H Maddox, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-939-9587 Fax: 205-975-4623 |